Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

PURPOSE: National hepatitis B virus (HBV) screening recommendations for patients with cancer anticipating systemic anticancer therapy range from universal screening to screening based on risk of HBV infection, cancer therapy–specific risk of HBV reactivation, or both. We conducted cost-effectiveness...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Clin Cancer Inform
Main Authors: Hwang, Jessica P., Huang, Danmeng, Vierling, John M., Suarez-Almazor, Maria E., Shih, Ya-Chen Tina, Chavez-MacGregor, Mariana, Duan, Zhigang, Giordano, Sharon H., Hershman, Dawn L., Fisch, Michael J., Cantor, Scott B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6874018/
https://ncbi.nlm.nih.gov/pubmed/30892921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.18.00097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados